Background. Mounting evidence indicates an increased risk of cognitive impairment in adults with end-stage kidney disease on dialysis, but the extent and pattern of deficits across the spectrum of cognitive domains are uncertain. Methods. We conducted a cross-sectional study of 676 adult hemodialysis patients from 20 centers in Italy, aiming to evaluate the prevalence and patterns of cognitive impairment across five domains of learning and memory, complex attention, executive function, language and perceptual-motor function. We assessed cognitive function using a neuropsychological battery of 10 tests and calculated test and domain z-scores using population norms (age or age/education). We defined cognitive impairment as a z-score À1.5. Results. Participants' median age was 70.9 years (range 21.6-94.1) and 262 (38.8%) were women. Proportions of impairment on each domain were as follows: perceptual-motor function 31.5% (150/476), language 41.2% (273/662), executive function 41.7% (281/674), learning and memory 42.2% (269/638), complex attention 48.8% (329/674). Among 474 participants with data for all domains, only 28.9% (n ¼ 137) were not impaired
functional impairment, hospitalization, increased use of health care resources, withdrawal from dialysis and death [4, 8, [10] [11] [12] . The causative mechanisms underlying the excess risk of cognitive impairment in dialysis patients are uncertain, but may include vascular disease, uremic neurotoxicity, chronic inflammation, oxidative stress, anemia and risks associated with dialysis itself (e.g. intradialytic cerebral ischemia, dialysis disequilibrium syndrome, hypercoagulability) [4, [13] [14] [15] [16] . The extent and patterns of impairment across the range of cognitive domains are also not yet well established, with most available studies small or focused on a subset of cognitive functions [6] [7] [8] [9] . A comprehensive understanding of the spectrum of cognitive impairment in dialysis patients is an important step toward tailoring clinical care for patients with reduced cognitive function, exploring the underlying mechanisms and developing interventions.
The COGNITIVE-HD study [17] aimed to examine the prevalence and patterns of cognitive impairment across five domains (learning and memory, complex attention, executive function, language, perceptual-motor function) in adult patients with ESKD on hemodialysis.
M A T E R I A L S A N D M E T H O D S

Design and population
This is a cross-sectional baseline analysis from the COGNITIVE-HD study [17] , a cohort study of patients recruited from 20 centers within a dialysis network in Italy between July 2013 and April 2014 ( Figure 1 ). Patients were included if they were community-dwelling, had ESKD, were being treated with outpatient hemodialysis (any duration), were at least 18 years old, were considered able to participate by their treating team and consented. Patients were excluded if they were living in a nursing home, were considered by their treating team to be unable to participate (e.g. due to significant disability or medical comorbidity that would preclude them consenting or completing tests even if assisted, because they had a life expectancy <6 months or anticipated transplantation within 6 months or anticipated recovery of kidney function that would preclude outcome follow-up) or they did not understand the Italian language (as testing was conducted in Italian). Participants with a sensory or motor impairment were included but skipped the affected tests. The study was conducted in accordance with the Declaration of Helsinki and all participants (or representatives) provided informed consent. Demographic and clinical characteristics, aside from depression symptoms, were obtained from a centralized database via data linkage within 1 month of enrolment. Depression symptoms were assessed using the Hospital Anxiety and Depression Scale depression subscale (HADS-D) [18] , administered by research assistants or psychologists in the same session as the cognitive assessment. Comorbidities were grouped as follows: coronary heart disease (angina, myocardial infarction, coronary bypass graft or coronary angioplasty), peripheral vascular disease (limb claudication or amputation) and cardiac arrhythmia (atrial fibrillation or other arrhythmia).
Outcome measurement
Five cognitive domains were assessed (learning and memory, complex attention, executive function, language, perceptualmotor function), defined as per the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) [19] . Each domain was assessed using two validated neuropsychological tests, with tests assessing more than one domain categorized under their primary domain. Tests in the battery were selected by an expert neurology and neuropsychology team who considered the following criteria: psychometric properties, availability of Italian test norms, maximizing content validity within each domain, minimizing battery duration, practicality of administration during dialysis and relevance to clinical practice. The learning and memory domain comprised immediate and delayed recall subtests of the Rey Auditory Verbal Learning Test (RAVLT), which measure verbal episodic memory functions [20] . The complex attention domain comprised the Symbol Digit Modalities Test (SDMT) [21] to assess sustained attention and processing speed and the digit span forward (DSF) test [22] to measure attentional capacity. The executive function domain comprised the digit span backward (DSB) test [22] to assess working memory and the F-A-S phonemic fluency test (FAS) [23] to measure cognitive organization, initiation and execution of an executive search strategy. The language domain was assessed using the Repeatable Battery for the Assessment of Neuropsychological Status [24] Semantic Fluency (RBANS-SF) and Picture Naming (RBANS-PN) subtests, which cover semantic fluency and naming functions. The perceptual-motor function domain was assessed using the RBANS [24] Figure Copy (RBANS-FC) and Line Orientation (RBANS-LO) subtests to evaluate organizational and visuoconstructional abilities and visuospatial orientation, respectively. The battery was administered by trained neuropsychologists during dialysis treatment. Testing took $ 30 min and was conducted in Italian.
Analytic methods
Patient characteristics were summarized using clinically relevant categories or tertiles as appropriate. The HADS-D cutoff was derived from a validation study in dialysis patients [25] . Univariate logistic regressions were used to compare key characteristics of included participants with patients excluded due to missing cognitive data. To calculate cognitive performance and impairment, we used Italian norms to convert raw test scores to test z-scores and composite domain z-scores. For language and perceptual-motor function, the domain z-score was calculated directly from the two raw test scores using RBANS instructions. Therefore, participants with missing data on either test were coded as missing for the domain and test z-scores were not available for these domains. Age and education norms were used [26] . For learning and memory, executive function and complex attention, the domain z-score was calculated as a mean of the two test z-scores for that domain. Where participants had missing data for one test, their score on the other was used, so only participants with missing data for both had to be coded as missing for the domain. We chose the composite average approach to defining impairment for these domains over a categorical approach (e.g. impairment on at least one test) to maximize comparability to the RBANS-defined domains. Only age norms were available for these tests [20, 27, 28] . We defined test and domain impairment as a z-score À1.5 [at least 1.5 standard deviations (SDs) below the normative population mean], the midpoint of the range (1-2 SD) provided as guidance for mild cognitive disorders in the DSM-5 [19] .
We conducted a sensitivity analysis excluding the 36 patients with dialysis vintage <3 months or missing vintage, given that patients who have recently commenced dialysis could differ from those who are more established. We also conducted a sensitivity analysis to check the comparability of our results across dialysis vintage, stratifying patients into four vintage groups (<5 years, 5-9.9 years, 10-14.9 years, !15 years). Finally, we conducted sensitivity analyses to consider the impact of missing cognitive data, reestimating proportions and patterns of impairment under the assumption that missing data for a domain indicated normal performance for that domain (best-case analysis) and then that it indicated impaired performance (worstcase analysis). All analyses were conducted in SAS Studio (SAS Institute, Cary, NC, USA). Figure 3 was created using ConceptDraw PRO 11.0.0.3 (CS Odessa, San Jose, CA, USA).
R E S U L T S
Participant characteristics
Overall, 676 of 958 patients (70.6%) participated ( Figure 1) , with 207 patients preferring not to participate [n ¼ 72 (7.5%)]
or not meeting eligibility criteria [n ¼ 135 (14.1%)]. We excluded 75 patients (7.8%) due to missing data for all cognitive domains (n ¼ 65) or other reasons (n ¼ 10). Compared with included participants, the 65 patients excluded for missing outcome data were older and had higher Charlson comorbidity and HADS-D scores, but did not differ significantly with respect to gender or educational attainment (Supplementary data, Table S1 ).
Participants were 22-94 years of age (median 71) and 38.8% were women ( Table 1 ). The most frequent comorbidities were hypertension (76.7%), diabetes (27.0%) and coronary heart disease (22.8%). Seventeen participants (2.5%) had experienced a stroke. Almost 90% of participants were retired or not employed, and around half had not attained secondary education. The median time treated with dialysis was 4 years, ranging from newly commenced (1 day) to 38 years.
Performance and impairment across cognitive tests
On average, performance was below the normative population mean for all available test scores (Table 2) , with median z-scores ranging from À0.83 (phonemic fluency test) to À1.62 (digit span backward and forward tests). Proportions of participants with impaired test scores (z-score À1.5) ranged from $30% (phonemic fluency test) to 57% (digit span forward test). Across all available tests, a considerable proportion of participants performed above the impairment threshold but still below the relevant age-adjusted population norm (À1.5 < z-score < 0; Supplementary data, Figure S1 ). This was particularly the case for the SDMT and digit span backward tests in the attention and executive function domains.
Performance and impairment across cognitive domains
Composite domain z-scores ranged from À0.92 for perceptual-motor function to À1.46 for complex attention and, on average, performance was below normative expectations for all domains ( Table 2) . Proportions of impairment (domain z-score À1.5) were as follows: 31.5% for perceptual-motor function [95% confidence interval (CI) 27.3-35.7), 41.2% for language (95% CI 37.5-45.0), 41.7% for executive function (95% CI 38.0-45.4), 42.2% for learning and memory (95% CI 38.3-46.0) and 48.8% for complex attention (95% CI 45.0-52.6). Similar to test scores, a considerable proportion of participants had domain z-scores between À1.5 and 0 (Figure 2 ), indicating performance below normative expectations but above the impairment threshold. Missing cognitive data ( Table 2) was highest for the perceptual-motor function domain (29.6%) and SDMT (26.5%). All other tests and domains were <10%.
Patterns of impairment co-occurrence across cognitive domains
Among patients with complete cognitive data (n ¼ 474), only 28.9% (95% CI 24.8-33.0; n ¼ 137) demonstrated no impairment on any domain, with 25.9% (95% CI 22.0-29.9; n ¼ 123) impaired on a single domain, 17.3% (95% CI 13.9-20.7; n ¼ 82) on two domains, 13.9% (95% CI 10.8-17.1; n ¼ 66) on three domains, 9.1% (95% CI 6.5-11.7; n ¼ 43) on four domains and 4.9% (95% CI 2.9-6.8; n ¼ 23) on all five domains.
Patterns of impairment co-occurrence were widely distributed across these 474 patients ( Figure 3 ). Aside from no impairment, the most common patterns were single-domain impairments of language (6.8%), perceptual-motor function (6.8%), learning and memory (5.7%) and complex attention (5.3%), then all five domains combined (4.8%), with the remainder distributed across 26 other impairment combinations (all <4%).
Sensitivity analyses
Impairment patterns were comparable to the primary analysis when excluding the 36 patients with dialysis vintage <3 months or missing vintage. Proportions of domain-specific impairment ranged from 31.9% for perceptual-motor function to 50.3% for complex attention, with 71.8% of patients with complete cognitive data impaired on at least one domain (Supplementary data, Table S2 ). While there was some variability in the extent and patterns of cognitive impairment across vintage groups (Supplementary data, Table S3 and Table S4 ), especially for the longest vintage, results were fairly consistent with the primary analysis. In the best-case sensitivity analysis for missing data (missing domain coded as not impaired), proportions of domain-specific cognitive impairment ranged from 20.2% for perceptual-motor function to 44.4% for complex attention, with 71.1% of patients impaired on at least one domain (Supplementary data, Table S5 ). In the worst-case analysis (missing domain coded as impaired), proportions of impairment ranged from 47.0% for executive function to 56.0% for perceptual-motor function, with 81.5% of patients impaired on at least one domain (Supplementary data, Table S5 ).
D I S C U S S I O N
Our findings indicate a considerable burden of cognitive impairment in this population, with an estimated 71.1% of patients being impaired on at least one domain and impairment being common across all five domains of learning and memory, complex attention, executive function, language and perceptualmotor function. Considering patterns in terms of relative levels of impairment, the estimated prevalence of domain-specific impairment ranged from $30% for perceptual-motor function to $50% for complex attention, with the other three domains being $40%. Co-occurrence of impairment across domains was very common, with 45.2% of patients impaired on two or more domains. Further, patterns of impairment co-occurrence were Denominators vary, as percentages are calculated based on the total number of participants with non-missing data for that covariate, as specified in the 'Variable' column.
highly variable across patients, displaying the diversity and complexity of cognitive impairment in this population. Our finding that >70% of older hemodialysis patients are impaired on at least one cognitive domain is consistent with previous studies, albeit smaller cohorts and with some variability in definitions [6] [7] [8] [9] . Among 338 hemodialysis patients [7] of similar average age to our study, 87% were found to be impaired on at least one cognitive domain (!1.5 SD below population norms), with considerable proportions impaired on memory, executive function and language tests ($30-50%). Another study involving 145 dialysis patients [8] of average age 50 years found that 68% were impaired on at least two tests (! 1 SD below norms), with considerable proportions ($20-60%) impaired on executive function/attention, memory and perceptual-motor function tests. In another study [6] of 314 hemodialysis patients, impairment (>1.5 SD below norms) on memory tests ranged from 1 to 30%, and from 4 to 40% across attention/executive function tests. The relatively lower proportions in the latter study may reflect a population that was younger on average and had higher levels of education than our study, from which patients with advanced dementia had been excluded. In addition to a high proportion of patients meeting the cognitive impairment threshold, our study also identified a downward shift in cognitive performance for hemodialysis patients. That is, aside from the perceptual-motor domain, very few patients had cognitive performance at or above average expectations for their age and/or education.
Considering relative levels of impairment across domains, we found that although impairment was common across all five domains, the prevalence was highest for complex attention. The complex attention domain assessed cognitive functions including processing speed, sustained attention and attentional capacity. The greatest proportion of test impairment outside this domain was for the digit span backwards test, which FIGURE 2: Distribution of standardized performance (z-scores) for each cognitive domain. Domain z-scores are a composite of participants' normed performance on tests within that domain. For language and perceptual-motor function, performance is standardized relative to age and education norms, and for all other domains performance is standardized relative to age norms only. The dark shading indicates impaired cognitive performance (i.e. z-score À1.5).
primarily assesses working memory skills and sits under the executive function domain. These results suggest that dialysis patients may be particularly impaired on cognitive functions such as attention, processing speed and working memory within the complex attention and executive function domains. This is consistent with a recent meta-analysis [5] of studies comparing hemodialysis patients to within-study controls on Lezak's [29] cognitive domains. Hemodialysis patients performed significantly worse than controls on all domains except perception (for which data were limited), with the poorest performance for orientation/attention. As the orientation/attention domain was defined to include working memory as well as attention, sustained attention and processing speed, it encompasses the cognitive functions that were most commonly impaired in our study. Given the common predominance of attention/executive impairments in vascular-related cognitive impairment, compared with memory predominance in neurodegenerative-related impairment [30] , alongside the significant burden of vascular disease in ESKD, these findings suggest that vascular mechanisms may play a key role in this population [15] . There is a growing body of work investigating vascular risk factors. Recent work in this area indicates that arterial stiffness is an independent cross-sectional predictor of cognitive impairment, with a hypothesized causal pathway via cerebral microvascular damage [31, 32] . Causal investigations are complicated by the fact that the profiles of vascular and neurodegenerative cognitive impairment are not entirely distinct [19] , risk factors may operate through both vascular and neurodegenerative pathways [15] and vascular and neurodegenerative processes may interact [13] . Further, ESKD and dialysis may impact cognitive functioning through unique nephrogenic and dialysis-related pathways [13] . For example, recent evidence indicates that intradialytic cerebral ischemia is common in hemodialysis patients and predicts executive function decline at 12 months [33] . In light of the potential complexity of underlying mechanisms, future research should focus on identifying risk factors for cognitive decline, with consideration of multiple mechanisms and pathways in longitudinal designs. Such work has already commenced [34, 35] and will be critical to the development of targeted prevention and treatment strategies.
We also investigated patterns of impairment co-occurrence, finding that a considerable proportion of patients experienced multiple cognitive deficits simultaneously and patterns of impairment across patients were very diverse. Associations between cognitive functions and both health literacy and adherence in other populations [36] [37] [38] [39] [40] [41] suggest that cognitive impairment is likely to compromise patients' capacities to self-manage their disease and adhere to the complex treatment regimens associated with ESKD [13, 42] . Similarly, a range of cognitive skills (e.g. processing speed, sustained attention, working memory, receptive language) are likely to influence a patient's ability to discuss and understand information about treatment options such as dialysis modality, transplantation and end-of-life care and reason through this information to make decisions (e.g. short-term memory, planning, decision making) [43, 44] . Indeed, a recent pilot study demonstrated an association between cognitive impairment and reduced decisional capacity in chronic kidney disease and dialysis patients [45] . To add further complexity, existing evidence indicates that associations of cognition with health literacy, adherence and decisional abilities may vary across the spectrum of different cognitive functions [37, 38, 40, 43, 44] . Thus our findings suggest that older hemodialysis patients are affected by a diverse range of cognitive deficits, often multidimensional, with the potential to impact their treatment experience in different ways.
There is therefore a need to routinely take cognitive function into account in the clinical care of ageing patients with ESKD, using strategies tailored to their specific needs. Given the current absence of proven preventive and curative interventions for cognitive impairment [46] [47] [48] , relevant clinical actions center on early identification and effective management. These include cognitive screening (using tests that are validated in ESKD patients and cover all relevant domains including executive function) with referral for further assessment/diagnosis where appropriate [13, 47, 49, 50] , tailored communication and patient education (e.g. simplified instructions, chunking of information, actionable language, effective use of visual aids) [51, 52] , assessment of self-management capacity with caregiver involvement and tailored strategies to facilitate selfmanagement where needed [36, 51, 53] , risk management, symptom management [46] , assessment of decision-making capacity alongside action to enhance capacity or identify substitute decision makers where necessary [54] and timely end-oflife discussions and advanced care planning [55, 56] . It is also important to support caregivers of patients with cognitive impairment, who may be at increased risk of depression [46] . Implementation of these strategies should be tailored to patients' physical, psychological and social needs as well as their cultural background and preferences and requires multidisciplinary collaboration [13, 46] . As there has been little work evaluating interventions specifically in ESKD, there is also a clear need for research to identify what is most effective in this group [47] .
Our study has several strengths. This is a large study and we recruited a considerable proportion ($70%) of our population of interest, using a multicenter design and including all patients who were willing and able to participate to maximize representativeness and precision. Cognitive assessment consisted of a standardized and validated battery with strong reliability and criterion validity, administered by trained neuropsychologists, and scaled using relevant norms. The assessment also had strong content validity, indexing multiple cognitive functions within five domains, which allowed us to examine impairment patterns and co-occurrence.
There are some potential limitations. As in some other studies [6, 11] , patients were tested during dialysis, which is a limitation given the evidence of acute reductions in cognitive function (i.e. delirium) during dialysis [57, 58] . This may have led to an overestimation of cognitive impairment. Further, patients were tested at variable points within the dialysis session and across the week due to resource constraints, which may have introduced variability. However, the impact of test timing on cognitive performance is currently unresolved, as some recent randomized crossover trial evidence indicates no decline in cognitive performance during dialysis relative to predialysis, at least in the first hour [59] . Further, cognitive assessment during dialysis has ecological validity advantages, as patient education and communication often occur during this time [59] . Second, our results may not generalize to dialysis populations in other countries, given cross-country differences in the characteristics of dialysis populations [60] . Patients in our study tended to have lower educational attainment, fewer comorbidities, longer vintage and were less ethnically diverse than those in North American studies, and included some individuals in a younger age bracket [6, 7, 9] . These factors may impact cognitive performance. Third, 29.4% of patients in the network could not be included due to refusal, inability to consent/participate according to the treating team, other ineligibility or missing cognitive data for all domains. While the impact of incomplete participation is uncertain, these attributes might be associated with poorer cognitive ability (e.g. if physicians suggested more cognitively impaired patients would be unable to take part) and thus may have led to an underestimate of impairment prevalence and/or severity. Missing data for individual tests and domains (highest for the SDMT and perceptual-motor function domain) may have biased our results in a similar way. While we did not have individual-level reasons for missing data, the main reasons for noncompletion were sensory impairment, motor impairment or lack of motivation. Recent evidence indicates that patients with missing cognitive data for such reasons differ from patients with complete cognitive data on factors that are relevant to cognitive performance [61] . However, this is a common challenge and we explored possible impacts of missing data in sensitivity analyses, finding similar patterns of relative impairment across domains to our primary analyses except with regard to perceptual-motor function. There is some uncertainty regarding relative levels of impairment for this domain due to missing data.
There are also some limitations related to the tests and norms. We were unable to adjust for gender due to the unavailability of relevant norms and similarly could only adjust for education in language and perceptual-motor function. Given that our sample had relatively low levels of educational attainment, this may have led to an overestimation of cognitive impairment for learning and memory, complex attention and executive function relative to language and perceptual-motor function. As our study was cross-sectional, we were not able to measure cognitive decline and assess cognitive disorders as per DSM-5 criteria. Finally, interpretation and comparison to previous work were complicated by the fact that some domains overlap, some tests index multiple domains [62] and tests and domains have been classified differently across studies. We support calls for a standardized set of cognitive measures and outcomes [5] .
In conclusion, this study indicates that cognitive impairment is extremely common among older hemodialysis patients across a broad spectrum of domains, that individual patients often experience multiple deficits and that patterns of impairment cooccurrence are very diverse. There is a clear need for research to clarify underlying mechanisms and identify targets for preventive and curative interventions, as well as tailored clinical care practices to support dialysis patients with cognitive impairment.
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